Sphingosine pathway deregulation in endometriotic tissues

Expression of sphingosine-1-phosphate catabolic enzymes and receptors is altered in endometriosis. These modifications enhance the sphingosine-1-phosphate axis, promoting survival and angiogenesis. This may contribute to the establishment and development of endometriosis.

0
0

Authors

Pietro Santulli, M.D., Louis Marcellin, M.D., Jean-Christophe Noël, M.D., Ph.D., Bruno Borghese, M.D., Ph.D., Isabelle Fayt, M.D., Daniel Vaiman, Ph.D., Charles Chapron, M.D., Céline Méhats, Ph.D.

Volume 97, Issue 4, Pages 904-911.e5

Abstract

Objective:

To investigate key genes expression of the sphingosine-1-phosphate pathway in endometriotic tissues.

Design:

A case-control laboratory study.

Setting:

Tertiary care university hospital.

Patient(s):

A total of 31 women, with (n = 16) and without (n = 15) endometriosis took part in the study.

Intervention(s):

After surgical excision with pathological analysis, endometrial specimens were obtained from women affected or not by endometriosis.

Main Outcome Measure(s):

SPHK1-2, SGPP1-2, SGPL1, SPHKAP, and S1PR1-5 messenger RNA expression by quantitative real-time polymerase chain reaction (PCR) in the endometrium of 15 disease-free women, 16 eutopic and 16 ectopic endometrium of endometriosis-affected women. The S1PR1 and S1PR2 expression were further investigated by immunohistochemistry.

Result(s):

The SGPP2 expression was decreased in eutopic and ectopic endometrium of endometriosis-affected women (1.7- and 16.7-fold, respectively). The SGPP1, weakly expressed in healthy endometrium, is up-regulated in endometriosis-affected women (11.9- and 64.7-fold, respectively), but its expression remains low. The SGPL1 expression was decreased in ectopic endometrium (3.3-fold) and SPHKAP expression was increased in ectopic endometrium (112.6-fold) compared with endometrium of disease-free women. In endometriosis-affected women, S1PR3 expression was decreased in eutopic and ectopic endometrium (2.1- and 6.3-fold, respectively); S1PR2 and S1PR1 expression was increased in eutopic (2.5-fold) and ectopic endometrium (2.6-fold). These increases were confirmed at the protein levels by immunohistochemistry.

Conclusion(s):

Expression of the enzymes implicated in the regulation of the sphingosine-1-phosphate level balance and of its receptors is overall heavily deregulated in endometriotic lesions in favor of a decreased sphingosine-1-phosphate catabolism. Our results plead for a role of the sphingosine pathway in establishing and survival of endometriotic lesions.

Read the full text at: http://www.fertstert.org/article/S0015-0282(11)02935-9/fulltext

Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.